Terms: = Breast cancer AND MAP2K4, MEK4, 6416, P45985, ENSG00000065559, SERK1, JNKK1, MKK4, PRKMK4, MAPKK4, JNKK, SEK1
64 results:
1. The Interaction between Macrophages and Triple-negative breast cancer Cells Induces ROS-Mediated Interleukin 1α Expression to Enhance Tumorigenesis and Metastasis.
Hao M; Huang B; Wu R; Peng Z; Luo KQ
Adv Sci (Weinh); 2023 Oct; 10(29):e2302857. PubMed ID: 37551997
[TBL] [Abstract] [Full Text] [Related]
2. mkk4 Inhibitors-Recent Development Status and Therapeutic Potential.
Katzengruber L; Sander P; Laufer S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108658
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low breast cancers: A Retrospective, Multicenter Cohort Study.
Yang L; Liu Y; Han D; Fu S; Guo S; Bao L; Shi Y; Huang R; Wan H; Li W; Wang Z; Zhou X; Chen G; Liu Y; Ye F
Ann Surg Oncol; 2023 Sep; 30(9):5653-5662. PubMed ID: 37000356
[TBL] [Abstract] [Full Text] [Related]
4. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer.
He Y; Mei J; Hao H; Liu F; Yi Y; Hu C; Zou F; Lu X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6931-6941. PubMed ID: 36840755
[TBL] [Abstract] [Full Text] [Related]
5. Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review.
Lei T; Shi YQ; Chen TB
Diagn Pathol; 2023 Feb; 18(1):13. PubMed ID: 36737820
[TBL] [Abstract] [Full Text] [Related]
6. HER2-driven breast cancer suppression by the JNK signaling pathway.
Itah Z; Chaudhry S; Raju Ponny S; Aydemir O; Lee A; Cavanagh-Kyros J; Tournier C; Muller WJ; Davis RJ
Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2218373120. PubMed ID: 36656864
[TBL] [Abstract] [Full Text] [Related]
7. A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-mkk4-p38 axis in triple negative breast cancer.
Wang L; Mi D; Hu J; Liu W; Zhang Y; Wang C; Chen Y; Chen C
Cancer Lett; 2023 Feb; 555():216049. PubMed ID: 36608865
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Barbirou M; Miller AA; Gafni E; Mezlini A; Zidi A; Boley N; Tonellato PJ
Sci Rep; 2022 May; 12(1):8458. PubMed ID: 35589867
[TBL] [Abstract] [Full Text] [Related]
9. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
Siraj MA; Jacobs AT; Tan GT
Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
[TBL] [Abstract] [Full Text] [Related]
10. Mobile element insertions and associated structural variants in longitudinal breast cancer samples.
Steely CJ; Russell KL; Feusier JE; Qiao Y; Tavtigian SV; Marth G; Jorde LB
Sci Rep; 2021 Jun; 11(1):13020. PubMed ID: 34158539
[TBL] [Abstract] [Full Text] [Related]
11. Effects of astaxanthin on metastasis suppressors in ductal carcinoma. A preliminary study.
Badak B; Aykanat NEB; Kacar S; Sahinturk V; Arik D; Canaz F
Ann Ital Chir; 2021; 92():565-574. PubMed ID: 34096509
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/mek4-mediated MAPK signal pathway.
Zhang M; Wang Y; Jiang L; Song X; Zheng A; Gao H; Wei M; Zhao L
J Exp Clin Cancer Res; 2021 Jan; 40(1):41. PubMed ID: 33494806
[TBL] [Abstract] [Full Text] [Related]
13. Discovery of Covalent mkk4/7 Dual Inhibitor.
Jiang J; Jiang B; He Z; Ficarro SB; Che J; Marto JA; Gao Y; Zhang T; Gray NS
Cell Chem Biol; 2020 Dec; 27(12):1553-1560.e8. PubMed ID: 32916088
[TBL] [Abstract] [Full Text] [Related]
14. Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory breast cancer.
Winn JS; Hasse Z; Slifker M; Pei J; Arisi-Fernandez SM; Talarchek JN; Obeid E; Baldwin DA; Gong Y; Ross E; Cristofanilli M; Alpaugh RK; Fernandez SV
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075053
[TBL] [Abstract] [Full Text] [Related]
15. The Association of Modifiable breast cancer Risk Factors and Somatic Genomic Alterations in breast Tumors: The cancer Genome Atlas Network.
Heng YJ; Hankinson SE; Wang J; Alexandrov LB; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; Eliassen AH; Tamimi RM; Kraft P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):599-605. PubMed ID: 31932411
[TBL] [Abstract] [Full Text] [Related]
16. Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Conforti F; Pala L; Pagan E; Viale G; Bagnardi V; Peruzzotti G; De Pas T; Bianco N; Graffeo R; Rocco EG; Vingiani A; Gelber RD; Coates AS; Colleoni M; Goldhirsch A
Breast Cancer Res; 2019 Dec; 21(1):153. PubMed ID: 31888717
[TBL] [Abstract] [Full Text] [Related]
17. map2k4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis.
Liu S; Huang J; Zhang Y; Liu Y; Zuo S; Li R
Aging (Albany NY); 2019 Nov; 11(22):10697-10710. PubMed ID: 31761784
[TBL] [Abstract] [Full Text] [Related]
18. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway.
Wu X; Chen S; Lu C
Int J Mol Med; 2020 Jan; 45(1):162-174. PubMed ID: 31746365
[TBL] [Abstract] [Full Text] [Related]
19. Combined mTORC1/mTORC2 inhibition blocks growth and induces catastrophic macropinocytosis in cancer cells.
Srivastava RK; Li C; Khan J; Banerjee NS; Chow LT; Athar M
Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24583-24592. PubMed ID: 31732667
[TBL] [Abstract] [Full Text] [Related]
20. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
Hoffman J; Fejerman L; Hu D; Huntsman S; Li M; John EM; Torres-Mejia G; Kushi L; Ding YC; Weitzel J; Neuhausen SL; Lott P; ; Echeverry M; Carvajal-Carmona L; Burchard E; Eng C; Long J; Zheng W; Olopade O; Huo D; Haiman C; Ziv E
Breast Cancer Res; 2019 Jan; 21(1):3. PubMed ID: 30642363
[TBL] [Abstract] [Full Text] [Related]
[Next]
